Health House International Limited
Limited financial coverage for HHI.AX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Founded in 2011 and headquartered in Perth, Australia, Health House International Limited focuses on distributing medicinal cannabis products throughout Australasia, the United Kingdom, and Europe. The company provides a variety of pharmaceutical supplies to a broad customer base, including pharmacies, hospitals, government agencies, emergency medical services, and other wholesale distributors. Formerly known as Health House Holdings Limited until its renaming in March 2021, Health House International Limited has been operating as a subsidiary of Creso Pharma Limited since May 5, 2023.
- CEO
- David Colin Wheeler F.A.C.I.D.
- IPO
- 2021
- HQ
- Perth, WA, AU
Get TickerSpark's AI analysis on HHI.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.40
- RSI (14)
- 43
- Avg Volume
- 425.96K
No earnings-call transcripts are available for HHI.AX yet.
- Free Float
- 64.1%
- Shares Outstanding
- 178.22M
- Float Shares
- 114.22M
Our HHI.AX coverage
Recent articles, reports, and earnings notes.
No research on HHI.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HHI.AX report →